The Senate passed the Feinstein-Mikulski amendment late last night. This amendment provides an additional $390 million in cancer funding, with increases of:
- $240 million for the NCI
- $4.6 million for the National Center on Minority Health and Health Disparities
- $117 million for cancer programs at the CDC
- $25 million for the Nurse Reinvestment Act and Nursing Programs at HRSA
“Coming on the heels of our dramatic victory yesterday on the Specter Harkin amendment, we have accomplished much in a very difficult fiscal environment. The success of both these amendments puts the United States Senate clearly on record strongly opposing the President’s cuts to cancer funding, and will greatly strengthen our negotiating position as we enter the all important appropriations process this summer and fall,” says Dan Smith, VP of the American Cancer Society and Chair of One Voice Against Cancer.
“The Senate has a track record of supporting cancer research and prevention,” says Nancy Roach, C3 President. “The House will be a challenge. Stay tuned!”